hotspot -WSS

hotspot

author：fashion 2025-09-27 10:02:24 - browse：6951

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

focus

WSS

FDA approves Moderna’s RSV vaccine, its second licensed product

Study: New antibiotic targets gonorrhea as well as last existing drug

FTC loses bid to block Novant's North Carolina hospital merger

ASCO Daily Recap: CAR

Victims of gun violence feel impacts long after bullet wound

CMS got Medicare Advantage quality rating wrong, judge rules

leisure time

hotspot

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves Recor Medical high blood pressure device

Walensky prepares to leave CDC — and Congress — behind

FDA approves potent Eli Lilly obesity drug, Zepbound

ChatGPT in medicine: STAT answers readers' burning questions

ASCO Daily Recap: CAR

ChatGPT in medicine: STAT answers readers' burning questions

Senate panel clears PBM, hopsital reforms

New air purifier tech could be key to improving indoor air quality

STAT wants to know your pick for a great summer read or listen

focus

Take antibiotics after sex, CDC recommends for certain risk groups

Fight over Supreme Court dialysis ruling puts kidney patients at risk

White House calls on federal agencies to crack down on AI abuses

HPV cancer vaccine study demonstrates efficacy

Structure Therapeutics oral GLP

Biotech incubator Curie.Bio graduates its first startup

focus

leisure time

focus

knowledge